These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. Mukoyama M; Nakao K; Hosoda K; Suga S; Saito Y; Ogawa Y; Shirakami G; Jougasaki M; Obata K; Yasue H J Clin Invest; 1991 Apr; 87(4):1402-12. PubMed ID: 1849149 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors. Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats. Hirata Y; Suzuki E; Hayakawa H; Matsuoka H; Sugimoto T; Kangawa K; Matsuo H J Cardiovasc Pharmacol; 1994 Feb; 23(2):283-90. PubMed ID: 7511759 [TBL] [Abstract][Full Text] [Related]
25. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure. Wegner M; Hirth-Dietrich C; Stasch JP Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure. Elsner D; Müntze A; Kromer EP; Riegger GA Am J Cardiol; 1992 Aug; 70(4):494-8. PubMed ID: 1386491 [TBL] [Abstract][Full Text] [Related]
27. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt. Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733 [TBL] [Abstract][Full Text] [Related]
28. Increased plasma levels of adrenomedullin in patients with heart failure. Nishikimi T; Saito Y; Kitamura K; Ishimitsu T; Eto T; Kangawa K; Matsuo H; Omae T; Matsuoka H J Am Coll Cardiol; 1995 Nov; 26(6):1424-31. PubMed ID: 7594065 [TBL] [Abstract][Full Text] [Related]
29. Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. Moe GW; Grima EA; Wong NL; Howard RJ; Armstrong PW J Am Coll Cardiol; 1996 Mar; 27(3):720-7. PubMed ID: 8606288 [TBL] [Abstract][Full Text] [Related]
30. Effect of chronic neutral endopeptidase inhibition on cardiac hypertrophy after experimental myocardial infarction. Yoshida K; Yasujima M; Casley DJ; Johnston CI Jpn Circ J; 1998 Sep; 62(9):680-6. PubMed ID: 9766707 [TBL] [Abstract][Full Text] [Related]
31. Neutral endopeptidase 24.11 inhibition may not exhibit beneficial haemodynamic effects in patients with congestive heart failure. Kentsch M; Otter W; Drummer C; Nötges A; Gerzer R; Müller-Esch G Eur J Clin Pharmacol; 1996; 51(3-4):269-72. PubMed ID: 9010697 [TBL] [Abstract][Full Text] [Related]
32. Clearance mechanisms of atrial and brain natriuretic peptides in rats. Hashimoto Y; Nakao K; Hama N; Imura H; Mori S; Yamaguchi M; Yasuhara M; Hori R Pharm Res; 1994 Jan; 11(1):60-4. PubMed ID: 8140057 [TBL] [Abstract][Full Text] [Related]
33. [Atrial natriuretic factor and brain natriuretic peptide. Variations in elderly subjects with heart failure]. Tissandier O; Nasr A; Rainfray M; Hamon-Vilcot B; Piette F Presse Med; 1995 Dec; 24(38):1837-41. PubMed ID: 8545437 [TBL] [Abstract][Full Text] [Related]
34. EC 24.11 inhibition in man alters clearance of atrial natriuretic peptide. Richards AM; Wittert G; Espiner EA; Yandle TG; Frampton C; Ikram H J Clin Endocrinol Metab; 1991 Jun; 72(6):1317-22. PubMed ID: 1827451 [TBL] [Abstract][Full Text] [Related]